References
- Mortelé KJ, Rocha TC, Streeter JL, Taylor AJ. Multimodality imaging of pancreatic and biliary congenital anomalies. Radiographics. 2006;26(3):715–731. 10.1148/rg.263055164.
- Schawkat K, Manning MA, Glickman JN, Mortele KJ. Pancreatic ductal adenocarcinoma and its variants: Pearls and perils. Radiographics. 2020;40(5):1219–1239. 10.1148/rg.2020190184.
- Garces‑Descovich A, Beker K, Jaramillo‑Cardoso A, James Moser A, Mortele KJ. Applicability of current NCCN guidelines for pancreatic adenocarcinoma resectability: Analysis and pitfalls. Abdom Radiol (NY). 2018;43(2):314–322. 10.1007/s00261-018-1459-6.
- Beker K, Lee KS, Tsai LL, et al. Differentiation of pancreatic head ductal adenocarcinoma from inflammatory pancreatic pseudomass by MR cholangio‑pancreatography: Utility of the duct‑interrupted, corona, and attraction signs. Abdom Radiol (NY). 2019;44(12):4048–4056. 10.1007/s00261-019-02155-4.
- Mortelé KJ. Cystic pancreatic neoplasms: Imaging features and management strategy. Semin Roentgenol. 2013;48(3):253–263. 10.1053/j.ro.2013.03.006.
- Sahni VA, Mortelé KJ. The bloody pancreas: MDCT and MRI features of hypervascular and hemorrhagic pancreatic conditions. AJR Am J Roentgenol. 2009;192(4):923–935. 10.2214/AJR.08.1602.
- Souza D, Alessandrino F, Ketwaroo GA, Sawhney M, Mortele KJ. Accuracy of a novel noninvasive secretin‑enhanced MRCP severity index scoring system for diagnosis of chronic pancreatitis: Correlation with EUS‑based Rosemont criteria. Radiol Med. 2020;125(9):816–826. 10.1007/s11547-020-01181-3.